Estropipate is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Estropipate.
| Product ID | 0591-0415_fc393e85-ce9e-4647-aac8-77b231b38abf |
| NDC | 0591-0415 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Estropipate |
| Generic Name | Estropipate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 1993-09-23 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA081214 |
| Labeler Name | Actavis Pharma, Inc. |
| Substance Name | ESTROPIPATE |
| Active Ingredient Strength | 2 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1993-09-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA081214 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1993-09-23 |
| Marketing End Date | 2019-11-30 |
| Marketing Category | ANDA |
| Application Number | ANDA081214 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1993-09-23 |
| Marketing Category | ANDA |
| Application Number | ANDA081214 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1993-09-23 |
| Ingredient | Strength |
|---|---|
| ESTROPIPATE | 1.5 mg/1 |
| SPL SET ID: | 4252d631-03d0-4b37-8a0e-c7dc8fc5438a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0591-0414 | Estropipate | Estropipate |
| 0591-0415 | Estropipate | Estropipate |
| 0591-0416 | Estropipate | Estropipate |